Skip to content

Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation

Left Ventricular Reverse Remodeling Outcomes Evaluation in Patients With Aortic Regurgitation After Surgical Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06805253
Acronym
ORMIX
Enrollment
120
Registered
2025-02-03
Start date
2024-05-09
Completion date
2030-05-31
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Regurgitation, Diastolic Heart Failure, Left Atrium Dilated, Left Ventricle Dilated, Mitral Valve Regurgitation, Systolic Left Ventricular Heart Failure

Keywords

reverse remodeling, left ventricle dilatation, mitral valve functional regurgitation recovery, left ventricle reverse remodeling

Brief summary

Investigators assume that surgical correction approach to functional mitral regurgitation during intervention for chronic aortic regurgitation in patients with severe enlargement of the left heart chambers influences reverse remodeling of the left ventricle (LV) in the postoperative period. It is suggested that functional mitral regurgitation (MR) provides supra-physiological left ventricle volume overload and this fact plays positive role in early-stage post-operative left ventricle volume and function recovery. LV volume, systolic and diastolic function will be monitored with echocardiography (EchoCG) along with life quality in patients with different grades of functional mitral regurgitation secondary to severe chronic aortic insufficiency after surgical treatment of aortic regurgitation.

Interventions

Sponsors

Voronezh regional clinical hospital #1
CollaboratorUNKNOWN
Petrovsky National Research Centre of Surgery
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Planned primary elective surgery for chronic aortic regurgitation * Presence of functional mitral regurgitation * End-diastolic volume of the left ventricle >= 250 ml

Exclusion criteria

* Infectious endocarditis * History of myocardial infarction * Indications on simultaneous myocardial revascularisation * Acute aortic regurgitation of any etiology * Previously diagnosed dilatation of the left ventricle, not associated with the development of aortic regurgitation * Long-term persistent or permanent form of atrial fibrillation * Pregnancy in the first 12 months after surgery * Simultaneous participation in other studies * Presence of implanted pacemakers * Refusal to sign informed consent * Acute coronary event diagnosed within 12 months after aortic valve surgery * Indications for resynchronization therapy or permanent right ventricular pacing in the first 12 months after aortic valve surgery * Re-do cardiac surgery for any reason within 12 months after aortic valve surgery

Design outcomes

Primary

MeasureTime frameDescription
LV end-diastolic volume (EDV) decrease3 and 12 months after surgeryChange in end-diastolic volume of the left ventricle, assessed with EchoCG after surgical correction of aortic insufficiency
Freedom from readmission12 months after surgeryFreedom from readmission due to valvular problem or heart failure-related reason

Secondary

MeasureTime frameDescription
Life qualityUpon inclusion, 10 days post-surgery, 3 month and 12 month post-surgeryThe patient's life quality according to the results of the EuroQol-5D-5L (EQ-5D-5L) questionnaire (0-100 points, the higher - the better).

Other

MeasureTime frameDescription
LV ejection fraction (EF)3 and 12 month post-surgeryLeft ventricle ejection fraction, assessed with EchoCG
LV diastolic functionUpon inclusion, 3 month and 12 month post-surgeryLeft ventricle diastolic function, assessed with EchoCG
Left atrium volume index (LAVI)Upon inclusion, 3 month and 12 month post-surgeryLeft atrium volume indexed to body surface area, assessed with EchoCG

Countries

Russia

Contacts

Primary ContactEduard Charchyan, professor
charchmed@yahoo.com+79262174114
Backup ContactAndrei Bulynin
bandrew@inbox.ru+79081339584

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026